Cat. No. Name Size Price Add Cart
KI0279BMS-7081635 mg$299.2
BMS-70816310 mg$563.2
BMS-70816350 mg$1707.2
BMS-708163200 mg$4347.2

Chemical Characteristic

Product NameBMS-708163
SynonymsAvagacestat
CAS No.1146699-66-2
Molecular Weight 520.88
FormulaC20H17ClF4N4O4S
Chemical Name(2R)-2-[(4-chlorophenyl)sulfonyl-[[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide
SmilesC(=O)([C@@H](CCC(F)(F)F)N(Cc1c(cc(cc1)c1nocn1)F)S(=O)(=O)c1ccc(cc1)Cl)N
Chemical Structure

Biological activities

BMS-708163 is a potent and selective γ-secretase inhibitor of Aβ40 and Aβ42 with IC50 of 0.3 and 0.27 nM, respectively. BMS-708163 is used for the treatment of Alzheimer's disease. BMS-708163 potently inhibits the formation of Aβ40 and Aβ42 in H4-8Sw cells. BMS-708163 exhibits potency for inhibition of Notch processing with IC50 values of 58 nM. BMS-708163 exhibits weak potency for inhibition of Cytochrome P-450 (CYP) isoform 2C19 with IC50 value of 20 µM.[1] BMS-708163 has an only 3-fold selectivity for cleavage of an amyloid precursor protein (APP) substrate compared with a Notch substrate. BMS-708163 has a 7-fold selective inhibition for Aβ40 compared with Notch intracellular domain (NICD). Furthermore, an excess of BMS-708163 (1 µM) completely blocks the 163-BPyne labeling of presenilin-1 (PS1) in HeLa cell membrane preparations.[2] In both rats and dogs following iv doses BMS-708163(1 and 10 mg/kg), plasma concentrations of BMS-708163 exhibits a multiexponential decline. The total body clearance of BMS-708163 is low in both species (rat =11.7 mL/min/kg; dog = 4.20 mL/min/kg). Oral bioavailability from solution formulations of BMS-708163 is 105 and 42% in rats and dogs, respectively. In addition, BMS-708163 demonstrats a high brain to plasma ratio (brainconcn/plasmaconcn = 2.4) in dogs. In female rats, BMS-708163 significantly reduces both plasma and brain Aβ40 levels relative to control at 10 and 100 mg/kg for the entire dosing interval. In brain, BMS-708163 demonstrates significant Aβ40 lowering for 8 hours after an oral dose of 1mg/kg. BMS-708163 (ranging from 3 to 100 mg/kg) also significantly lowers cerebrospinal fluid (CSF) Aβ40 levels in rats. In male beagle dogs administered a single oral dose of BMS-708163 (2 mg/kg), Aβ40 measurements from the frontal cortex and CSF shows a rapid and sustained reduction in brain and CSF Aβ40 levels.[1]

Protocols

BMS-708163 is diluted in DMSO. [1]

References

[1] Kevin W. Gillman, et al. Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor. Med Chem Lett. 2010, 1(3): 120-124.
[2] Crump CJ, et al. BMS-708,163 Targets Presenilin and Lacks Notch-Sparing Activity. Biochemistry. 2012, 51(37): 7209-7211.

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.